GW & Wade »

Karyopharm Therapeutics shares owned by GW & Wade

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by GW & Wade from 13F filings

Historical chart of GW & Wade investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by GW & Wade consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by GW & Wade

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 45k 0.86
2023-09-30 $60k 45k 1.33

More positions owned by GW & Wade

Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Wisdomtree Tr Us Largecap Divd (DLN)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Exxon Mobil Corporation (XOM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Broadcom (AVGO)
Ishares Tr Rus 1000 Val Etf (IWD)
Procter & Gamble Company (PG)

View all positions for GW & Wade

Top funds holding Karyopharm Therapeutics

Vanguard Group
Eversept Partners
Palo Alto Investors
Adage Capital Partners GP
BlackRock
Citadel Advisors
Marshall Wace
Avidity Partners Management
Bnp Paribas Arbitrage, Snc
GSA Capital Partners
CAM Group Holding A/S
Jpmorgan Chase & Co
Geode Capital Management
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft

View all funds holding Karyopharm Therapeutics